CD4 and experimental autoimmune encephalomyelitis: In the present study, we administered Lycium barbarum glycopeptide to a mouse model of experimental autoimmune encephalomyelitis-an animal model of multiple sclerosis-and evaluated its effects on pathogenic CD4 + T cell activation both in vivo and in vitro .